## Abstract ## Purpose: To determine the sensitivity and specificity of MR elastography (MRE) in the staging of hepatic fibrosis (HF) using histopathology as the reference standard in an Asian population. ## Materials and Methods: MRE was performed on 55 patients with chronic liver diseases or b
Test–retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C
✍ Scribed by Norah J. Shire; Meng Yin; Jun Chen; Radha A. Railkar; Sabrina Fox-Bosetti; Stephanie M. Johnson; Chan R. Beals; Bernard J. Dardzinski; Schuyler O. Sanderson; Jayant A. Talwalkar; Richard L. Ehman
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 419 KB
- Volume
- 34
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Purpose:
To conduct a rigorous evaluation of the repeatability of liver stiffness assessed by MR elastography (MRE) in healthy and hepatitis‐C‐infected subjects.
Materials and Methods:
A biopsy‐correlated repeatability study using four‐slice MRE was conducted in five healthy and four HCV‐infected subjects. Subjects were scanned twice on day 1 and after 7–14 days. Each slice was acquired during a 14‐s breath‐hold with a commercially available acquisition technique (MR‐Touch, GE Healthcare). Results were analyzed by two independent analysts.
Results:
The intraclass correlation coefficient (ICC) was 0.85 (90% confidence interval [CI]: 0.71 to 0.98) for the between‐scan average of maximum stiffness within each slice and 0.88 (90% CI: 0.78 to 0.99) for the average of mean stiffness within each slice for the primary analyst. For both analysts, the average of the mean liver stiffness within each slice was highly reproducible with ICC of 0.93 and 0.94. Within‐subject coefficients of variation ranged from 6.07% to 10.78% for HCV+ and healthy subjects.
Conclusion:
MRE is a highly reproducible modality for assessing liver stiffness in HCV patients and healthy subjects and can discriminate between moderate fibrosis and healthy liver. MRE is a promising modality for noninvasive assessment of liver fibrosis (Clinicaltrials.gov identifier: NCT00896233). J. Magn. Reson. Imaging 2011;. © 2011 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Liver fibrosis is the main predictor of the progression of chronic hepatitis C, and its assessment by liver biopsy (LB) can help determine therapy. However, biopsy is an invasive procedure with several limitations. A new, noninvasive medical device based on transient elastography has been designed t
Liver biopsy is recommended before antiviral treatment, particularly for patients with hepatitis C virus (HCV) genotype 1 infection, but it may cause complications and is limited by sampling error. Several non-invasive tests comprising routine laboratory parameters (simple fibrosis tests) have been
The purpose of this study was to assess the influence of success rate and interquartile range on the accuracy of transient elastography for the diagnostic of fibrosis in hepatitis C virus infection. Two-hundred fifty-four consecutive patients had liver stiffness measurements and liver biopsy of at l
HCV infection is common among patients with end-stage renal disease (ESRD) on hemodialysis, and it has been considered an independent risk factor for mortality in this setting. Although liver biopsy in ESRD patients with HCV infection is useful before kidney transplantation, it carries a high risk o
Cale `s1,2 and multicentric groups from SNIFF 32, VINDIAG 7, and ANRS/HC/EP23 FIBROSTAR studies The sequential algorithm for fibrosis evaluation (SAFE) and the Bordeaux algorithm (BA), which cross-check FibroTest with the aspartate aminotransferase-to-platelet ratio index (APRI) or FibroScan, are v